| 2025 | 2024 | 2023 | 2022 | |||||
|---|---|---|---|---|---|---|---|---|
| Profit/loss | -2,3 M € | -12.7% | -2,1 M € | +59.8% | -5,1 M € | -1207.5% | -392,6 k € | |
| Equity | 2,9 M € | -10.0% | 3,3 M € | -32.4% | 4,8 M € | +248.5% | -3,2 M € | |
| Gross margin | 409,4 k € | -85.2% | 2,8 M € | +1329.2% | -225,3 k € | -141.6% | 541,1 k € | |
| Staff | 5,6 | 15 | 16,6 | — | ||||
Key indicators
| Unit no. | Name | Location |
|---|---|---|
| 2349033855 | EXO BIOLOGICS | Boulevard de Patience et Beaujonc 3 box 2, 4000 Liège |
Public limited company · Liège · incorporated on 29/08/2019 · 5,6 ETP
Public limited company en perte sur le dernier exercice. Trésorerie en repli (-84.5 %).
Source: filing of 16/07/2026
7-day free trial, no credit card required.
Source: Belgian Official Gazette